ClinicalTrials.govpublic full text
An Efficacy, Safety and Pharmacokinetics Study of Simeprevir, Daclatasvir and Sofosbuvir in Participants With Chronic Hepatitis C Virus Genotype 1 or 4 Infection and Decompensated Liver Disease
hepatitis c, chronic, simeprevir, daclatasvir, sofosbuvir, decompensated liver disease, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 806353
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.